Eleva Capital SAS
In its 13F for Q1 2026 (holdings as of March 31, 2026, filed April 15, 2026), Eleva Capital SAS reported 24 stock positions worth $343.4 million. Its top holding was CRH (CRH) at 81.3% of the portfolio, followed by Amer Sports (AS, 2.9%) and Nvidia (NVDA, 2.6%).
- Most Recent 13F
- Q2 2026
- Location
- PARIS, I0
- CIK
- 0002054496
- Portfolio Value
- $343.4M (Q1 2026)
- SEC Filing
- 0002054496-26-000002 ↗ filed Apr 15, 2026
Holdings Value
Holdings 24 stocks · $343.4M
| CRH CRH PLC | 81.27% | 2,654,974 | $279.1M | — |
| AS Amer Sports Inc. | 2.86% | 298,802 | $9.8M | — |
| NVDA Nvidia Corp. | 2.64% | 52,002 | $9.1M | — |
| NFLX Netflix Inc. | 2.44% | 87,190 | $8.4M | — |
| GOOGL Alphabet Inc. Class A | 2.34% | 27,967 | $8.0M | — |
| TSM Taiwan Semiconductor-SP ADR | 1.89% | 21,411 | $6.5M | — |
| ANET Arista Networks Inc. | 1.68% | 46,957 | $5.8M | — |
| AMZN Amazon.com Inc. | 0.98% | 16,155 | $3.4M | — |
| TMUS T-Mobile US Inc. | 0.88% | 14,347 | $3.0M | — |
| HOOD Robinhood Markets Inc. Class A | 0.64% | 31,625 | $2.2M | — |
| ONON On Holding AG Class A filed as ON HLDG AG | 0.50% | 50,150 | $1.7M | — |
| BSX Boston Scientific Corp. | 0.49% | 26,667 | $1.7M | — |
| SPOT Spotify Technology SA | 0.38% | 2,715 | $1.3M | — |
| NAMS Newamsterdam Pharma Co. NV | 0.24% | 25,721 | $823K | — |
| CGON CG Oncology Inc. | 0.16% | 8,289 | $561K | — |
| ESPR Esperion Therapeutics Inc. | 0.15% | 183,047 | $502K | — |
| MLYS Mineralys Therapeutics Inc. | 0.13% | 17,081 | $463K | — |
| FENC Fennec Pharmaceuticals Inc. | 0.10% | 53,234 | $327K | — |
| IRON Disc Medicine Inc. | 0.10% | 5,115 | $327K | — |
| VRDN Viridian Therapeutics Inc. | 0.04% | 7,126 | $139K | — |
| FCX Freeport-McMoran Inc. | 0.04% | 2,258 | $133K | — |
| ACHR Archer Aviation Inc. Class A | 0.03% | 21,534 | $111K | — |
| EWTX Edgewise Therapeutics Inc. | 0.02% | 17,460 | $55K | — |
| AQST Aquestive Therapeutics Inc. | 0.00% | 2,720 | $11K | — |
Portfolio Sells Q1 2026
No earlier filing to compare with.
Portfolio Buys Q1 2026
No earlier filing to compare with.